Acrivon Therapeutics(ACRV)

持股变动声明

Acrivon Therapeutics(ACRV)02-17 06:15

$Acrivon Therapeutics(ACRV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000762  Size: 4 KB 网页链接

超过5%股东持股披露「修订」

Acrivon Therapeutics(ACRV)02-14 22:55

$Acrivon Therapeutics(ACRV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001626  Act: 34  Size: 52 KB 网页链接

持股变动声明

Acrivon Therapeutics(ACRV)02-17 06:25

$Acrivon Therapeutics(ACRV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000765  Size: 4 KB 网页链接

当期报告

Acrivon Therapeutics(ACRV)03-04 21:25

$Acrivon Therapeutics(ACRV)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-056937  Act: 34  Size: 177 KB 网页链接

超过5%股东持股披露「修订」

Acrivon Therapeutics(ACRV)04-12 04:25

$Acrivon Therapeutics(ACRV)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-046306  Act: 34  Size: 93 KB 网页链接

其他

Acrivon Therapeutics(ACRV)04-26 20:35

$Acrivon Therapeutics(ACRV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-048673  Act: 34  Size: 2 MB 网页链接

股东委托书协议

Acrivon Therapeutics(ACRV)04-26 20:35

$Acrivon Therapeutics(ACRV)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-048671  Act: 34  Size: 3 MB 网页链接

当期报告

Acrivon Therapeutics(ACRV)02-08 21:35

$Acrivon Therapeutics(ACRV)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-027629  Act: 34  Size: 178 KB 网页链接

持股变动声明

Acrivon Therapeutics(ACRV)02-17 06:15

$Acrivon Therapeutics(ACRV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000760  Size: 5 KB 网页链接

年度财报

Acrivon Therapeutics(ACRV)03-28 19:45

$Acrivon Therapeutics(ACRV)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-037618  Act: 34  Size: 94 MB 网页链接

讨论

二麻麻04-09 19:08

$Acrivon Therapeutics(ACRV)$
$130M PIPE @ $8.50/share: The private placement is being led by a new US-based healthcare and life sciences investor and includes other new and key existing investors, including RA Capital Management, Perceptive Advisors, Paradigm BioCapital,...查看全文

讨论

SeekingBiotech2023-05-09 22:30

ACRV FDA Grants Fast Track Designation For Development Of ACR-368 In Platinum-Resistant Ovarian Cancer And Endometrial Cancer$Acrivon Therapeutics(ACRV)$查看全文

Aave社区发起使用金库中200万枚USDT购买CRV的ARFC提案

8月3日TuoniaoX.com消息，Aave社区发起以金库USDT购买CRV的ARFC提案，建议使用Aave DAO金库中的200万枚USDT战略性购买500万枚aCRV代币。提案称此次收购旨在支持DeFi生态系统，并在Curve wars中对Aave DAO进行战略定位，从而有利于GHO二级流动性。如... 网页链接

生效批准

$Acrivon Therapeutics(ACRV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001188  Act: 33  Size: 1 KB 网页链接

其他

$Acrivon Therapeutics(ACRV)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-048675  Act: 34  Size: 16 MB 网页链接

股东委托书协议

$Acrivon Therapeutics(ACRV)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-048671  Act: 34  Size: 3 MB 网页链接

其他

$Acrivon Therapeutics(ACRV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-048673  Act: 34  Size: 2 MB 网页链接

当期报告

$Acrivon Therapeutics(ACRV)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0000950170-24-047560  Act: 34  Size: 23 MB 网页链接

持股变动声明

$Acrivon Therapeutics(ACRV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001186  Size: 4 KB 网页链接

增发股票注册声明

$Acrivon Therapeutics(ACRV)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-099152  Act: 33  Size: 319 KB 网页链接

持股变动声明

$Acrivon Therapeutics(ACRV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010809  Size: 13 KB 网页链接

持股变动声明

$Acrivon Therapeutics(ACRV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-008378  Size: 8 KB 网页链接

超过5%股东持股披露「修订」

$Acrivon Therapeutics(ACRV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-095564  Act: 34  Size: 63 KB 网页链接